Tokyo, June 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061994) titled 'A Biomarker Exploratory Study of Zolbetuximab-Based Treatment for Gastric Cancer' on June 22.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center
Condition:
Condition - Patients with unresectable advanced or recurrent gastric cancer scheduled to receive zolbetuximab-containing chemotherapy
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - The aim of this study is to evaluate factors associated with sensitivity and acquired resistance to zolbetuximab-containing systemic chemotherapy in patients with gastric cancer. Gene expression and p...